Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
Cancer Renal Cell Cancer (RCC) Carcinoma Cholangiocarcinoma Pancreatic Cancer Papillary carcinoma Papillary Thyroid Cancer Solid Tumors Skin Cancer Malignant Melanoma Renal Cell Carcinoma Head and Neck Cancer Salivary gland cancer Sarcoma Non Hodgkin Lymphoma (NHL) Lymphoma Colorectal Cancer (CRC) Lung Cancer Non Small Cell Lung Carcinoma Tumor Neoplasms NeuroEndocrine Tumor (NET) Ovarian Cancer Breast Cancer Thyroid Cancer Melanoma Head and Neck Neoplasms
For the latest version of this information please go to www.forpatients.roche.com